Cargando…

Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21)

BACKGROUND: There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mak, Joyce W. Y., Sun, Yang, Limsrivilai, Julajak, Abdullah, Murdani, Kaibullayeva, Jamilya, Balderramo, Domingo, Vergara, Beatriz Iade, Paudel, Mukesh Sharma, Banerjee, Rupa, Hilmi, Ida, Ali, Raja Affendi Raja, Wei, Shu Chen, Ng, Ka Kei, Altuwaijri, Mansour, Kelly, Paul, Yamamoto-Furusho, Jesus K., Kotze, Paulo Gustavo, Ahuja, Vineet, Chong, Vui Heng, Dao, Hang Viet, Abbey, Yvonne, Ching, Jessica Y. L., Ho, Agnes, Chan, Alicia K. W., Bernstein, Charles N., Gearry, Richard B., Abreu, Maria, Rubin, David T., Dotan, Iris, Hracs, Lindsay, Kaplan, Gilaad G., Ng, Siew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209572/
https://www.ncbi.nlm.nih.gov/pubmed/37231405
http://dx.doi.org/10.1186/s12874-023-01944-2
_version_ 1785046905143689216
author Mak, Joyce W. Y.
Sun, Yang
Limsrivilai, Julajak
Abdullah, Murdani
Kaibullayeva, Jamilya
Balderramo, Domingo
Vergara, Beatriz Iade
Paudel, Mukesh Sharma
Banerjee, Rupa
Hilmi, Ida
Ali, Raja Affendi Raja
Wei, Shu Chen
Ng, Ka Kei
Altuwaijri, Mansour
Kelly, Paul
Yamamoto-Furusho, Jesus K.
Kotze, Paulo Gustavo
Ahuja, Vineet
Chong, Vui Heng
Dao, Hang Viet
Abbey, Yvonne
Ching, Jessica Y. L.
Ho, Agnes
Chan, Alicia K. W.
Bernstein, Charles N.
Gearry, Richard B.
Abreu, Maria
Rubin, David T.
Dotan, Iris
Hracs, Lindsay
Kaplan, Gilaad G.
Ng, Siew C.
author_facet Mak, Joyce W. Y.
Sun, Yang
Limsrivilai, Julajak
Abdullah, Murdani
Kaibullayeva, Jamilya
Balderramo, Domingo
Vergara, Beatriz Iade
Paudel, Mukesh Sharma
Banerjee, Rupa
Hilmi, Ida
Ali, Raja Affendi Raja
Wei, Shu Chen
Ng, Ka Kei
Altuwaijri, Mansour
Kelly, Paul
Yamamoto-Furusho, Jesus K.
Kotze, Paulo Gustavo
Ahuja, Vineet
Chong, Vui Heng
Dao, Hang Viet
Abbey, Yvonne
Ching, Jessica Y. L.
Ho, Agnes
Chan, Alicia K. W.
Bernstein, Charles N.
Gearry, Richard B.
Abreu, Maria
Rubin, David T.
Dotan, Iris
Hracs, Lindsay
Kaplan, Gilaad G.
Ng, Siew C.
author_sort Mak, Joyce W. Y.
collection PubMed
description BACKGROUND: There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect of environmental factors including diet on IBD development. METHODS: Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) is a population-based cohort of newly diagnosed persons with Crohn’s disease and ulcerative colitis in Asia, Africa, and Latin America to be followed prospectively for 12 months. New cases were ascertained from multiple sources and were entered into a secured online system. Cases were confirmed using standard diagnostic criteria. In addition, endoscopy, pathology and pharmacy records from each local site were searched to ensure completeness of case capture. Validated environmental and dietary questionnaires were used to determine exposure in incident cases prior to diagnosis. RESULTS: Through November 2022, 106 hospitals from 24 regions (16 Asia; 6 Latin America; 2 Africa) have joined the GIVES-21 Consortium. To date, over 290 incident cases have been reported. All patients have demographic data, clinical disease characteristics, and disease course data including healthcare utilization, medication history and environmental and dietary exposures data collected. We have established a comprehensive platform and infrastructure required to examine disease incidence, risk factors and disease course of IBD in the real-world setting. CONCLUSIONS: The GIVES-21 consortium offers a unique opportunity to investigate the epidemiology of IBD and explores new clinical research questions on the association between environmental and dietary factors and IBD development in newly industrialized countries. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-023-01944-2.
format Online
Article
Text
id pubmed-10209572
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102095722023-05-26 Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21) Mak, Joyce W. Y. Sun, Yang Limsrivilai, Julajak Abdullah, Murdani Kaibullayeva, Jamilya Balderramo, Domingo Vergara, Beatriz Iade Paudel, Mukesh Sharma Banerjee, Rupa Hilmi, Ida Ali, Raja Affendi Raja Wei, Shu Chen Ng, Ka Kei Altuwaijri, Mansour Kelly, Paul Yamamoto-Furusho, Jesus K. Kotze, Paulo Gustavo Ahuja, Vineet Chong, Vui Heng Dao, Hang Viet Abbey, Yvonne Ching, Jessica Y. L. Ho, Agnes Chan, Alicia K. W. Bernstein, Charles N. Gearry, Richard B. Abreu, Maria Rubin, David T. Dotan, Iris Hracs, Lindsay Kaplan, Gilaad G. Ng, Siew C. BMC Med Res Methodol Research BACKGROUND: There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect of environmental factors including diet on IBD development. METHODS: Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) is a population-based cohort of newly diagnosed persons with Crohn’s disease and ulcerative colitis in Asia, Africa, and Latin America to be followed prospectively for 12 months. New cases were ascertained from multiple sources and were entered into a secured online system. Cases were confirmed using standard diagnostic criteria. In addition, endoscopy, pathology and pharmacy records from each local site were searched to ensure completeness of case capture. Validated environmental and dietary questionnaires were used to determine exposure in incident cases prior to diagnosis. RESULTS: Through November 2022, 106 hospitals from 24 regions (16 Asia; 6 Latin America; 2 Africa) have joined the GIVES-21 Consortium. To date, over 290 incident cases have been reported. All patients have demographic data, clinical disease characteristics, and disease course data including healthcare utilization, medication history and environmental and dietary exposures data collected. We have established a comprehensive platform and infrastructure required to examine disease incidence, risk factors and disease course of IBD in the real-world setting. CONCLUSIONS: The GIVES-21 consortium offers a unique opportunity to investigate the epidemiology of IBD and explores new clinical research questions on the association between environmental and dietary factors and IBD development in newly industrialized countries. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-023-01944-2. BioMed Central 2023-05-25 /pmc/articles/PMC10209572/ /pubmed/37231405 http://dx.doi.org/10.1186/s12874-023-01944-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mak, Joyce W. Y.
Sun, Yang
Limsrivilai, Julajak
Abdullah, Murdani
Kaibullayeva, Jamilya
Balderramo, Domingo
Vergara, Beatriz Iade
Paudel, Mukesh Sharma
Banerjee, Rupa
Hilmi, Ida
Ali, Raja Affendi Raja
Wei, Shu Chen
Ng, Ka Kei
Altuwaijri, Mansour
Kelly, Paul
Yamamoto-Furusho, Jesus K.
Kotze, Paulo Gustavo
Ahuja, Vineet
Chong, Vui Heng
Dao, Hang Viet
Abbey, Yvonne
Ching, Jessica Y. L.
Ho, Agnes
Chan, Alicia K. W.
Bernstein, Charles N.
Gearry, Richard B.
Abreu, Maria
Rubin, David T.
Dotan, Iris
Hracs, Lindsay
Kaplan, Gilaad G.
Ng, Siew C.
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21)
title Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21)
title_full Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21)
title_fullStr Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21)
title_full_unstemmed Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21)
title_short Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21)
title_sort development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (gives-21)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209572/
https://www.ncbi.nlm.nih.gov/pubmed/37231405
http://dx.doi.org/10.1186/s12874-023-01944-2
work_keys_str_mv AT makjoycewy developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT sunyang developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT limsrivilaijulajak developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT abdullahmurdani developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT kaibullayevajamilya developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT balderramodomingo developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT vergarabeatriziade developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT paudelmukeshsharma developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT banerjeerupa developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT hilmiida developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT alirajaaffendiraja developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT weishuchen developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT ngkakei developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT altuwaijrimansour developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT kellypaul developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT yamamotofurushojesusk developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT kotzepaulogustavo developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT ahujavineet developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT chongvuiheng developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT daohangviet developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT abbeyyvonne developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT chingjessicayl developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT hoagnes developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT chanaliciakw developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT bernsteincharlesn developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT gearryrichardb developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT abreumaria developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT rubindavidt developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT dotaniris developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT hracslindsay developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT kaplangilaadg developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT ngsiewc developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21
AT developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21